Zhendong Li

机构：Sun Yat-sen University, Sun Yat-sen University Cancer Center, Liaoning Cancer Hospital & Institute · ORCID：0000-0002-3930-2888

发表论文 61 篇 · 总被引 66 次 · h-index 3

代表论文

• Efficacy and safety of the neoadjuvant chemoimmunotherapy with pembrolizumab plus docetaxel and cisplatin in resectable locally advanced squamous cell carcinoma of the head and neck (2025 · Frontiers in Immunology · 被引 1)
• FGF/FGFR Alteration Type as a Candidate Enrichment Biomarker for Gunagratinib in Recurrent or Metastatic Head and Neck Cancer: An Exploratory Analysis of Two Early-Phase Trials (2026 · Targeted Oncology)
• Efficacy and safety of toripalimab in combination with cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): a phase 1b/2 study (2026 · Signal Transduction and Targeted Therapy)
• Thymosin α1 Combined with PD-1/PD-L1 Inhibitor Plus Chemotherapy in Platinum-Resistant Recurrent Ovarian Cancer : A Retrospective Analysis (2025 · Cancer Management and Research)
• The β-1,6-glucanase MoGlu16 is Required for Mycelia Growth and Pathogenicity of Magnaporthe oryzae (2025 · Current Microbiology)
• Supplementary Figure S1 from Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase II Trial (2025)